Moreover, the recently identified MYCMI-6 and MYCMI-7 compounds, were shown to inhibit MYC/MAX hetero-dimerization and induce c-MYC and N-MYC protein degradation, exhibiting anticancer activity in in vivo tumor models20,21. Here, MYC is linked to neoplasm.